Cargando…
Establishing Best Practices and Guidance in Population Modeling: An Experience With an Internal Population Pharmacokinetic Analysis Guidance
This tutorial describes the development of a population pharmacokinetic (Pop PK) analysis guidance within Pfizer, which strives for improved consistency and efficiency, and a more systematic approach to model building. General recommendations from the Pfizer internal guidance and a suggested workflo...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483270/ https://www.ncbi.nlm.nih.gov/pubmed/23836283 http://dx.doi.org/10.1038/psp.2013.26 |
_version_ | 1783414004524253184 |
---|---|
author | Byon, W Smith, MK Chan, P Tortorici, MA Riley, S Dai, H Dong, J Ruiz‐Garcia, A Sweeney, K Cronenberger, C |
author_facet | Byon, W Smith, MK Chan, P Tortorici, MA Riley, S Dai, H Dong, J Ruiz‐Garcia, A Sweeney, K Cronenberger, C |
author_sort | Byon, W |
collection | PubMed |
description | This tutorial describes the development of a population pharmacokinetic (Pop PK) analysis guidance within Pfizer, which strives for improved consistency and efficiency, and a more systematic approach to model building. General recommendations from the Pfizer internal guidance and a suggested workflow for Pop PK model building are discussed. A description is also provided for mechanisms by which conflicting opinions were captured and resolved across the organization to arrive at the final guidance. CPT: Pharmacometrics & Systems Pharmacology (2013) 2, e51; doi:10.1038/psp.2013.26; advance online publication 3 July 2013 |
format | Online Article Text |
id | pubmed-6483270 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-64832702019-05-02 Establishing Best Practices and Guidance in Population Modeling: An Experience With an Internal Population Pharmacokinetic Analysis Guidance Byon, W Smith, MK Chan, P Tortorici, MA Riley, S Dai, H Dong, J Ruiz‐Garcia, A Sweeney, K Cronenberger, C CPT Pharmacometrics Syst Pharmacol Tutorial This tutorial describes the development of a population pharmacokinetic (Pop PK) analysis guidance within Pfizer, which strives for improved consistency and efficiency, and a more systematic approach to model building. General recommendations from the Pfizer internal guidance and a suggested workflow for Pop PK model building are discussed. A description is also provided for mechanisms by which conflicting opinions were captured and resolved across the organization to arrive at the final guidance. CPT: Pharmacometrics & Systems Pharmacology (2013) 2, e51; doi:10.1038/psp.2013.26; advance online publication 3 July 2013 John Wiley and Sons Inc. 2013-07-03 2013-07 /pmc/articles/PMC6483270/ /pubmed/23836283 http://dx.doi.org/10.1038/psp.2013.26 Text en © 2013 The Authors. CPT: Pharmacometrics & Systems Pharmacology published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/3.0/ Licence, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Tutorial Byon, W Smith, MK Chan, P Tortorici, MA Riley, S Dai, H Dong, J Ruiz‐Garcia, A Sweeney, K Cronenberger, C Establishing Best Practices and Guidance in Population Modeling: An Experience With an Internal Population Pharmacokinetic Analysis Guidance |
title | Establishing Best Practices and Guidance in Population Modeling: An Experience With an Internal Population Pharmacokinetic Analysis Guidance |
title_full | Establishing Best Practices and Guidance in Population Modeling: An Experience With an Internal Population Pharmacokinetic Analysis Guidance |
title_fullStr | Establishing Best Practices and Guidance in Population Modeling: An Experience With an Internal Population Pharmacokinetic Analysis Guidance |
title_full_unstemmed | Establishing Best Practices and Guidance in Population Modeling: An Experience With an Internal Population Pharmacokinetic Analysis Guidance |
title_short | Establishing Best Practices and Guidance in Population Modeling: An Experience With an Internal Population Pharmacokinetic Analysis Guidance |
title_sort | establishing best practices and guidance in population modeling: an experience with an internal population pharmacokinetic analysis guidance |
topic | Tutorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483270/ https://www.ncbi.nlm.nih.gov/pubmed/23836283 http://dx.doi.org/10.1038/psp.2013.26 |
work_keys_str_mv | AT byonw establishingbestpracticesandguidanceinpopulationmodelinganexperiencewithaninternalpopulationpharmacokineticanalysisguidance AT smithmk establishingbestpracticesandguidanceinpopulationmodelinganexperiencewithaninternalpopulationpharmacokineticanalysisguidance AT chanp establishingbestpracticesandguidanceinpopulationmodelinganexperiencewithaninternalpopulationpharmacokineticanalysisguidance AT tortoricima establishingbestpracticesandguidanceinpopulationmodelinganexperiencewithaninternalpopulationpharmacokineticanalysisguidance AT rileys establishingbestpracticesandguidanceinpopulationmodelinganexperiencewithaninternalpopulationpharmacokineticanalysisguidance AT daih establishingbestpracticesandguidanceinpopulationmodelinganexperiencewithaninternalpopulationpharmacokineticanalysisguidance AT dongj establishingbestpracticesandguidanceinpopulationmodelinganexperiencewithaninternalpopulationpharmacokineticanalysisguidance AT ruizgarciaa establishingbestpracticesandguidanceinpopulationmodelinganexperiencewithaninternalpopulationpharmacokineticanalysisguidance AT sweeneyk establishingbestpracticesandguidanceinpopulationmodelinganexperiencewithaninternalpopulationpharmacokineticanalysisguidance AT cronenbergerc establishingbestpracticesandguidanceinpopulationmodelinganexperiencewithaninternalpopulationpharmacokineticanalysisguidance |